1. J Med Chem. 2016 Oct 13;59(19):8848-8858. doi: 10.1021/acs.jmedchem.6b00676. 
Epub 2016 Sep 15.

Synthesis and Antiobesity Properties of 
6-(4-Chlorophenyl)-3-(4-((3,3-difluoro-1-hydroxycyclobutyl)methoxy)-3-methoxyphenyl)thieno[3,2-d]pyrimidin-4(3H)-one 
(BMS-814580): A Highly Efficacious Melanin Concentrating Hormone Receptor 1 
(MCHR1) Inhibitor.

Ahmad S(1), Washburn WN(1), Hernandez AS(1), Bisaha S(1), Ngu K(1), Wang W(1), 
Pelleymounter MA(1), Longhi D(1), Flynn N(1), Azzara AV(1), Rohrbach K(1), 
Devenny J(1), Rooney S(1), Thomas M(1), Glick S(1), Godonis H(1), Harvey S(1), 
Zhang H(1), Gemzik B(1), Janovitz EB(1), Huang C(1), Zhang L(1), Robl JA(1), 
Murphy BJ(1).

Author information:
(1)Metabolic Diseases Chemistry, ‡Metabolic Diseases Biology, §PCO MAP, ∥PCO 
Discovery Toxicology, and ⊥PCO Bioanalytical Research, Bristol-Myers Squibb 
Research & Development , P.O. Box 4000, Princeton, New Jersey 08543, United 
States.

The potent MCHR1 in vitro and in vivo antagonist activity of a series of cyclic 
tertiary alcohols derived from compound 2b is described. Subsequent 
pharmacokinetic and pharmacodynamic studies identified BMS-814580 (compound 10) 
as a highly efficacious antiobesity agent with a relatively clean in vitro and 
in vivo safety profile.

DOI: 10.1021/acs.jmedchem.6b00676
PMID: 27564419 [Indexed for MEDLINE]
